Thomas F. Butler

592 total citations
18 papers, 479 citations indexed

About

Thomas F. Butler is a scholar working on Molecular Biology, Organic Chemistry and Food Science. According to data from OpenAlex, Thomas F. Butler has authored 18 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Food Science. Recurrent topics in Thomas F. Butler's work include Probiotics and Fermented Foods (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Antifungal resistance and susceptibility (4 papers). Thomas F. Butler is often cited by papers focused on Probiotics and Fermented Foods (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Antifungal resistance and susceptibility (4 papers). Thomas F. Butler collaborates with scholars based in United States. Thomas F. Butler's co-authors include Robert S. Gordee, Nancy Snyder, Mark J. Zweifel, R. D. G. Cooper, DEBORAH L. MULLEN, Thalia I. Nicas, Michael Rodriguez, Stephen C. Wilkie, R. C. Thompson and J. R. Turner and has published in prestigious journals such as Annals of the New York Academy of Sciences, Antimicrobial Agents and Chemotherapy and Life Sciences.

In The Last Decade

Thomas F. Butler

17 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas F. Butler United States 11 228 170 150 123 63 18 479
R. NAGARAJAN United States 9 276 1.2× 178 1.0× 190 1.3× 238 1.9× 37 0.6× 10 577
Stephen C. Wilkie United States 5 262 1.1× 157 0.9× 225 1.5× 189 1.5× 45 0.7× 6 456
F. T. COUNTER United States 13 229 1.0× 84 0.5× 178 1.2× 234 1.9× 52 0.8× 26 555
D. M. BERRY United States 15 181 0.8× 123 0.7× 178 1.2× 80 0.7× 102 1.6× 22 561
Francesco Parenti Italy 15 330 1.4× 98 0.6× 160 1.1× 55 0.4× 39 0.6× 21 594
KOZO TOMATSU Japan 12 241 1.1× 94 0.6× 203 1.4× 246 2.0× 86 1.4× 17 564
J. L. OTT United States 14 372 1.6× 117 0.7× 289 1.9× 189 1.5× 39 0.6× 29 692
G. BERETTA Italy 11 378 1.7× 120 0.7× 370 2.5× 128 1.0× 51 0.8× 20 717
Leonard C. Howard United States 5 148 0.6× 158 0.9× 148 1.0× 45 0.4× 63 1.0× 7 387
Ivan A.D. Lessard United Kingdom 14 391 1.7× 156 0.9× 115 0.8× 71 0.6× 42 0.7× 14 791

Countries citing papers authored by Thomas F. Butler

Since Specialization
Citations

This map shows the geographic impact of Thomas F. Butler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Butler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Butler more than expected).

Fields of papers citing papers by Thomas F. Butler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Butler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Butler. The network helps show where Thomas F. Butler may publish in the future.

Co-authorship network of co-authors of Thomas F. Butler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Butler. A scholar is included among the top collaborators of Thomas F. Butler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Butler. Thomas F. Butler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zweifel, Mark J., Nancy Snyder, R. D. G. Cooper, et al.. (2003). Glycopeptide Carboxamides Active against Vancomycin-resistant Enterococci.. The Journal of Antibiotics. 56(3). 289–295. 5 indexed citations
2.
Falcone, Julie F., F.P. Bymaster, Thomas F. Butler, et al.. (1999). Determination of the intrinsic functional muscarinic activity of xanomeline. Life Sciences. 64(6-7). 579–579. 1 indexed citations
3.
Rodriguez, Michael, Nancy Snyder, Mark J. Zweifel, et al.. (1998). Novel Glycopeptide Antibiotics: N-Alkylated Derivatives Active Against Vancomycin-Resistant Enterococci.. The Journal of Antibiotics. 51(6). 560–569. 45 indexed citations
4.
Cooper, R. D. G., Nancy Snyder, Mark J. Zweifel, et al.. (1996). Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.. The Journal of Antibiotics. 49(6). 575–581. 151 indexed citations
5.
Wilkie, Stephen C., Nancy Snyder, Mark J. Zweifel, et al.. (1995). New semisynthetic glycopeptide antibiotics Structure-activity relationship of the N-alkylated disaccharide. 35. 156. 1 indexed citations
6.
Butler, Thomas F., C J Boylan, Peter Raab, et al.. (1992). Ly295337 a novel cyclic depsipeptide antifungal antibiotic iii resistance development studies. 32. 194. 1 indexed citations
7.
Debono, Manuel, Bernard J. Abbott, D. S. Fukuda, et al.. (1989). Synthesis of new analogs of echinocandin B by enzymatic deacylation and chemical reacylation of the echinocandin B peptide: Synthesis of the antifungal agent cilofungin (LY121019).. The Journal of Antibiotics. 42(3). 389–397. 43 indexed citations
8.
Debono, Manuel, Bernard J. Abbott, J. R. Turner, et al.. (1988). Synthesis and Evaluation of LY121019, a Member of a Series of Semisynthetic Analogues of the Antifungal Lipopeptide Echinocandin Ba. Annals of the New York Academy of Sciences. 544(1). 152–167. 56 indexed citations
9.
Butler, Thomas F., et al.. (1981). Procedure for Assay of Tobramycin in Serum Containing Moxalactam. Antimicrobial Agents and Chemotherapy. 19(5). 934–936.
10.
Turner, J. R., Thomas F. Butler, Robert S. Gordee, & Arvind L. Thakkar. (1978). A32390A, a new biologically active metabolite. III. In vitro and in vivo antifungal activity.. The Journal of Antibiotics. 31(1). 33–37. 8 indexed citations
11.
Turner, J. R., et al.. (1976). Colonization of the Intestinal Tract of Conventional Mice with Candida albicans and Treatment with Antifungal Agents. Antimicrobial Agents and Chemotherapy. 9(5). 787–792. 19 indexed citations
12.
Gordee, Robert S. & Thomas F. Butler. (1975). New azasteroidal antifungal antibiotics from Geotrichum flavo-brunneum. III. Biological activity.. The Journal of Antibiotics. 28(2). 112–117. 22 indexed citations
13.
Gordee, Robert S. & Thomas F. Butler. (1973). A9145, A NEW ADENINE-CONTAINING ANTIFUNGAL ANTIBIOTIC. The Journal of Antibiotics. 26(8). 466–470. 36 indexed citations
14.
Gordee, Robert S., Thomas F. Butler, & N. Narasimhachari. (1971). THE ANTIFUNGAL ACTIVITY OF DERMOSTATIN. The Journal of Antibiotics. 24(8). 561–565. 4 indexed citations
15.
Angelotti, Robert, et al.. (1968). Influence of Spore Moisture Content on the Dry-Heat Resistance of Bacillus subtilis var. niger. Applied Microbiology. 16(5). 735–745. 11 indexed citations
16.
Angelotti, Robert, et al.. (1968). Influence of Spore Moisture Content on the Dry-Heat Resistance of Bacillus subtilis var. niger. Applied Microbiology. 16(5). 735–745. 32 indexed citations
17.
Butler, Thomas F., Gerald L. Smith, & E. A. Grula. (1967). BACTERIAL CELL MEMBRANES: I. REAGGREGATION OF MEMBRANE SUBUNITS FROM MICROCOCCUS LYSODEIKTICUS. Canadian Journal of Microbiology. 13(11). 1471–1479. 28 indexed citations
18.
Grula, E. A., Thomas F. Butler, Robert D. King, & Gerald L. Smith. (1967). BACTERIAL CELL MEMBRANES: II. POSSIBLE STRUCTURE OF THE BASAL MEMBRANE CONTINUUM OF MICROCOCCUS LYSODEIKTICUS. Canadian Journal of Microbiology. 13(11). 1499–1507. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. NAGARAJAN Breakdown of academic impact, for papers by Stephen C. Wilkie Breakdown of academic impact, for papers by F. T. COUNTER Breakdown of academic impact, for papers by D. M. BERRY Breakdown of academic impact, for papers by Francesco Parenti Breakdown of academic impact, for papers by KOZO TOMATSU Breakdown of academic impact, for papers by J. L. OTT Breakdown of academic impact, for papers by G. BERETTA Breakdown of academic impact, for papers by Leonard C. Howard Breakdown of academic impact, for papers by Ivan A.D. Lessard
Rankless by CCL
2026